Skip to main content

Table 2 Lifetime risk (%) with 95% confidence interval of individual and composite major adverse renal and cardiovascular events by baseline disease status in T2D

From: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals

Baseline status Outcomes
HF CKD MI Stroke PAD CVD death MARCE
Reference: CVRD free 29.2 (27.5–29.7) 53.6 (52.6–54.1) 18.9 (17.2–19.3) 20.2 (18.5–20.6) 9.2 (8.1–9.5) 40.5 (40.0–41.1) 80.0 (79.7–80.4)
HF only 66.0 (65.2–70.6) 25.7 (21.6–29.4) 18.7 (13.2–21.7) 12.8 (8.8–15.5) 66.0 (65.0–69.4) 97.1 (97.1–100)
CKD only 34.7 (32.9–36.2) 20.7 (18.7–22.0) 20.3 (18.2–21.6) 13.0 (11.2–14.3) 45.7 (44.3–47.2) 93.3 (93.3–96.3)
MI only 44.0 (37.2–49.8) 53.2 (49.1–58.8) 24.4 (15.9–28.1) 14.3 (9.1–17.9) 60.3 (56.1–64.4) 97.6 (97.6–100)
Stroke only 28.8 (25.5–30.5) 54.5 (52.9–56.7) 23.8 (20.4–25.8) 12.3 (10.2–13.6) 56.2 (54.7–57.9) 89.2 (89.1–92.1)
PAD only 35.2 (30.0–38.4) 56.0 (53.8–61.4) 29.2 (21.4–33.7) 27.7 (21.0–31.8) 52.5 (49.0–56.0) 90.8 (90.8–98.9)
  1. Abbreviations: HF heart failure, CKD chronic kidney disease, CVD cardiovascular disease, MI myocardial infarction, MARCE major adverse renal cardiovascular events, PAD peripheral artery disease